EridanusPills logotype

Cart: Your cart is empty

    Payment Methods:
  • Visa payment logo
  • Mastercard payment logo

Hours of Operation 24/7

Buy Zivas

40 mg, 20 mg, 10 mg

Zivas tablets 40 mg, 20 mg, 10 mg image

Active ingredient: simvastatin

Buy Now
Categories of ZivasCholesterol Lowering
Average price (USD)$0.78 Vytorin
Manufacturer country (Worldwide Sale)Philippines
Medication ClassStatins

Zivas pills over the counter

Due to this medication increased risk of myopathy and rhabdomyolysis, the dose of Zivas should not exceed 10 mg daily http://eridanuspills.com/other-medications/viregyt.php patients taking http://eridanuspills.com/weight-loss-medications/dietil.php with other additionally, except including. Simvastatin is used to help reduce high levels of bad cholesterol and lessen the risks it can pose to your health. Therefore, the dose of simvastatin should not exceed 20 mg daily in patients receiving concomitant medication with amlodipine. Simvastatin can be taken by adults and children over the age of 10.

Side Effects

Possible side effects of Zivas include:

  • swelling
  • troubled breathing
  • cough
  • Dizziness
  • red, irritated eyes
  • increased urination

Used for

Zivas is used to treat diseases such as: Cardiovascular Risk Reduction, High Cholesterol, High Cholesterol, Familial Heterozygous, High Cholesterol, Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa, Elevated LDL, Hyperlipoproteinemia Type IIb, Elevated LDL VLDL, Hyperlipoproteinemia Type III, Elevated beta-VLDL IDL, Hyperlipoproteinemia Type IV, Elevated VLDL, Prevention of Cardiovascular Disease.

How to Use

  • Drinking alcohol when taking this medication can increase your risks of stomach bleeding and stomach ulcers.

Dosage & Overdose

They both work in the same way, but the doses vary. People can take it and still drive a car and go to work and remain fully present beings.

Warnings

  • Go to your doctor for advice if you stop or start smoking.
  • In addition, it was rationalized that application of this exclusion criterion would decrease the risk of indication bias, because patients initiated on a nonstandard regimen likely represent one or more different populations, which could potentially confound the results.

References

  • https://www.healthline.com/search?q1=Zivas